These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102. Status of methylthioadenosine phosphorylase and its impact on cellular response to L-alanosine and methylmercaptopurine riboside in human soft tissue sarcoma cells. Li W; Su D; Mizobuchi H; Martin DS; Gu B; Gorlick R; Cole P; Bertino JR Oncol Res; 2004; 14(7-8):373-9. PubMed ID: 15301428 [TBL] [Abstract][Full Text] [Related]
103. MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage. Kalev P; Hyer ML; Gross S; Konteatis Z; Chen CC; Fletcher M; Lein M; Aguado-Fraile E; Frank V; Barnett A; Mandley E; Goldford J; Chen Y; Sellers K; Hayes S; Lizotte K; Quang P; Tuncay Y; Clasquin M; Peters R; Weier J; Simone E; Murtie J; Liu W; Nagaraja R; Dang L; Sui Z; Biller SA; Travins J; Marks KM; Marjon K Cancer Cell; 2021 Feb; 39(2):209-224.e11. PubMed ID: 33450196 [TBL] [Abstract][Full Text] [Related]
104. Specific Targeting of Tang B; Lee HO; An SS; Cai KQ; Kruger WD Cancer Res; 2018 Aug; 78(15):4386-4395. PubMed ID: 29844120 [TBL] [Abstract][Full Text] [Related]
105. Molecular genetic analysis of chromosome 9p in methylthioadenosine phosphorylase deficient glioma cell lines. Wu DJ; Reynolds L; Carson DA; Nobori T Adv Exp Med Biol; 1991; 309B():207-11. PubMed ID: 1781369 [No Abstract] [Full Text] [Related]
106. Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma. Lou L; Li J; Qin M; Tian X; Guo W; Li Y Brain Tumor Pathol; 2023 Jan; 40(1):15-25. PubMed ID: 36550382 [TBL] [Abstract][Full Text] [Related]
107. Downregulation of MTAP promotes Tumor Growth and Metastasis by regulating ODC Activity in Breast Cancer. Zhang Y; Zhang TT; Gao L; Tan YN; Li YT; Tan XY; Huang TX; Li HH; Bai F; Zou C; Pei XH; Tan BB; Fu L Int J Biol Sci; 2022; 18(7):3034-3047. PubMed ID: 35541910 [TBL] [Abstract][Full Text] [Related]
108. Deletion of Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM Cancer Genomics Proteomics; 2022; 19(3):299-304. PubMed ID: 35430564 [TBL] [Abstract][Full Text] [Related]
110. Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Weaver-Feldhaus J; Gruis NA; Neuhausen S; Le Paslier D; Stockert E; Skolnick MH; Kamb A Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7563-7. PubMed ID: 8052620 [TBL] [Abstract][Full Text] [Related]
111. Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme. Kamatani N; Nelson-Rees WA; Carson DA Proc Natl Acad Sci U S A; 1981 Feb; 78(2):1219-23. PubMed ID: 6785752 [TBL] [Abstract][Full Text] [Related]
112. Enzyme deficiency and tumor suppressor genes: absence of 5'-deoxy-5'-methylthioadenosine phosphorylase in human tumors. Della Ragione F; Oliva A; Palumbo R; Russo GL; Zappia V Adv Exp Med Biol; 1993; 348():31-43. PubMed ID: 8172020 [No Abstract] [Full Text] [Related]
113. A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer. Kindler HL; Burris HA; Sandler AB; Oliff IA Invest New Drugs; 2009 Feb; 27(1):75-81. PubMed ID: 18618081 [TBL] [Abstract][Full Text] [Related]
114. MTAP loss: a possible therapeutic approach for glioblastoma. Patro CPK; Biswas N; Pingle SC; Lin F; Anekoji M; Jones LD; Kesari S; Wang F; Ashili S J Transl Med; 2022 Dec; 20(1):620. PubMed ID: 36572880 [TBL] [Abstract][Full Text] [Related]
115. Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Pomykala HM; Bohlander SK; Broeker PL; Olopade OI; Díaz MO Mol Cell Biol; 1994 Nov; 14(11):7604-10. PubMed ID: 7523863 [TBL] [Abstract][Full Text] [Related]
116. Deficiency of methylthioadenosine phosphorylase in human leukemic cells in vivo. Kamatani N; Yu AL; Carson DA Blood; 1982 Dec; 60(6):1387-91. PubMed ID: 6814551 [TBL] [Abstract][Full Text] [Related]
117. A transition state analogue of 5'-methylthioadenosine phosphorylase induces apoptosis in head and neck cancers. Basu I; Cordovano G; Das I; Belbin TJ; Guha C; Schramm VL J Biol Chem; 2007 Jul; 282(29):21477-86. PubMed ID: 17548352 [TBL] [Abstract][Full Text] [Related]
118. Methylthioadenosine phosphorylase deficiency in tumors: A compelling therapeutic target. Fan N; Zhang Y; Zou S Front Cell Dev Biol; 2023; 11():1173356. PubMed ID: 37091983 [TBL] [Abstract][Full Text] [Related]
119. 6-thioguanine: a drug with unrealized potential for cancer therapy. Munshi PN; Lubin M; Bertino JR Oncologist; 2014 Jul; 19(7):760-5. PubMed ID: 24928612 [TBL] [Abstract][Full Text] [Related]
120. Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient. Dalal I; Grunebaum E; Cohen A; Roifman CM Clin Genet; 2001 Jun; 59(6):430-7. PubMed ID: 11453975 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]